paclitaxel has been researched along with Pleural Effusion, Malignant in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (12.90) | 18.2507 |
2000's | 15 (48.39) | 29.6817 |
2010's | 12 (38.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergzoll, C; Eva, L; Jamieson, A; Simcock, B; Sykes, P | 1 |
Fang, Z; Wang, Z; Zheng, Y | 1 |
Asami, K; Atagi, S; Hirashima, T; Kawaguchi, T; Kawase, I; Morishita, N; Nakao, K; Okamoto, N; Okishio, K; Otsuka, T; Shiroyama, T; Suzuki, H; Tamiya, A; Tamiya, M; Yamadori, T; Yasue, T | 1 |
Briones-Gómez, A; Cases-Viedma, E; Martínez-Tomás, R; Modesto-Alapont, M; Muñoz-Moya, MA | 1 |
Atagi, S; Hamaguchi, M; Hirashima, T; Kawaguchi, T; Morishita, N; Nakao, K; Okamoto, N; Okishio, K; Omachi, N; Shiroyama, T; Suzuki, H; Tamiya, A; Tamiya, M; Tani, E; Yasue, T | 1 |
Lai, FC; Li, X; Lin, JB; Lin, JW; Lin, M; Liu, B; Luo, RG; Qiu, ML; Tu, YR | 1 |
Du, N; Kang, H; Li, F; Li, X; Qi, N; Zhao, H | 1 |
Hosaka, M; Mitamura, T; Sakuragi, N; Takeda, M; Watari, H | 1 |
Chew, I; Park, KJ; Soslow, RA | 1 |
Chen, L; Lu, Y; Wang, X; Wang, Y; Wei, Y; Zhou, J; Zhu, Z | 1 |
Chen, L; Wang, X; Wei, Y; Zheng, H; Zhu, Z | 1 |
Abbruzzi, A; Bromberg, J; Chang, J; D'Andrea, G; Dang, C; Dickler, M; Fornier, MN; Gilewski, T; Hudis, CA; Modi, S; Morris, PG; Norton, L; Seidman, AD; Sklarin, N | 1 |
Dalla Palma, M; Donach, M; Fiduccia, P; Fiore, D; Gusella, M; Lombardi, G; Nicoletto, MO; Zagonel, V; Zuin, A | 1 |
Hachiya, T; Hama, M; Komatsu, Y | 1 |
An, J; Fisher, M; Rettig, MB; Sun, Y | 1 |
Aiba, K; Hagino, T; Hirano, A; Kawase, K; Kobayashi, M; Kobayashi, T; Okawa, Y; Shioya, H; Sugiyama, K; Uno, S; Usui, N; Yoshida, K | 1 |
Akedo, I; Kubo, M; Mori, M; Nakagawa, C; Nishida, Y; Ono, H; Sakai, K; Takeda, E; Tamura, K; Tsugawa, M; Yanagi, K | 1 |
Duivenvoorden, W; Matthews, D; Richard, C; Th'ng, JP; Wright, PS; Yau, J | 1 |
Endo, W; Fukunaga, H; Hojo, S; Maeura, Y; Ota, H; Yamazaki, K; Yoshioka, S | 1 |
Matsumoto, I; Ohta, Y; Shimizu, Y; Watanabe, G | 1 |
Duivenvoorden, WC; Richard, C; Th'ng, JP; Yau, J | 1 |
Suzuki, M | 1 |
Aoki, D; Banno, K; Hirao, N; Kawaguchi, M; Kuwabara, Y; Susumu, N; Tsukazaki, K; Yamagami, W; Yanokura, M | 1 |
Maxwell, GL; McGuire, WP; Muggia, F; Rose, GS; Rose, PG; Rubin, SC; Sundborg, MJ; Tian, C; Winter, WE | 1 |
Chen, YM; Lin, JY; Lin, SY; Perng, RP; Whang-Peng, J; Wu, MF | 1 |
Chen, YM; Chou, KC; Lin, WC; Liu, JM; Perng, RP; Whang-Peng, J; Wu, MF | 1 |
Asaoka, K; Ishitani, K; Iwasaki, K; Komuro, Y; Masumoto, N | 1 |
Funahashi, H; Hayashi, H; Imai, T; Itoh, T; Kikumori, T; Mase, T; Oiwa, M; Sekiya, M; Shibata, A | 1 |
Ashizawa, T; Katayanagi, S; Katsumata, K; Koyanagi, Y; Kusama, M; Murohashi, T; Sumi, T; Yamamoto, K | 1 |
Hanta, I; Hasturk, S; Soylu, M; Zeren, EH | 1 |
Hazama, K; Kagisaki, K; Matsuda, H; Miyoshi, S; Ohta, M; Shintani, Y | 1 |
1 review(s) available for paclitaxel and Pleural Effusion, Malignant
Article | Year |
---|---|
Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Paclitaxel; Pericardial Effusion; Pleural Effusion, Malignant; Taxoids; Thymus Neoplasms; Vena Cava, Superior | 2001 |
7 trial(s) available for paclitaxel and Pleural Effusion, Malignant
Article | Year |
---|---|
Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Sequential treatment strategy for malignant pleural effusion in non-small cell lung cancer with the activated epithelial grow factor receptor mutation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Male; Middle Aged; Mutation; Paclitaxel; Pleural Effusion, Malignant; Quinazolines | 2017 |
A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liposomes; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome | 2010 |
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Dasatinib; Edema; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion, Malignant; Pyrimidines; Thiazoles; Treatment Outcome | 2011 |
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drainage; Female; Humans; Instillation, Drug; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pleural Cavity; Pleural Effusion, Malignant; Tissue Distribution | 2012 |
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome; Vomiting | 1997 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drainage; Female; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Treatment Outcome | 1998 |
23 other study(ies) available for paclitaxel and Pleural Effusion, Malignant
Article | Year |
---|---|
Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Neoplasms, Glandular and Epithelial; New Zealand; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Quality of Life; Safety; Survival Analysis; Treatment Outcome | 2018 |
Insertion of a metallic guide-wire in the pleural cavity as a complication in tunneled indwelling pleural catheter placement.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Foreign Bodies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pleural Cavity; Pleural Effusion, Malignant; Thoracentesis | 2015 |
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion; Pleural Effusion, Malignant; Vascular Endothelial Growth Factor A | 2016 |
Combination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Bevacizumab; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A | 2016 |
Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Female; Humans; Injections; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Thorax; Time Factors | 2009 |
Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy: report of a case showing extensive clear cell changes mimicking clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cystadenocarcinoma, Serous; Diagnosis, Differential; Female; Humans; Hypercholesterolemia; Hypertension; Immunohistochemistry; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant | 2009 |
Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Drug Administration Routes; Humans; Linear Models; Liposomes; Middle Aged; Paclitaxel; Pleural Cavity; Pleural Effusion, Malignant; Sensitivity and Specificity | 2010 |
[A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pleural Effusion, Malignant; Tomography, X-Ray Computed | 2011 |
Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Boronic Acids; Bortezomib; Cell Division; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Synergism; Humans; Lymphoma; Membrane Glycoproteins; NF-kappa B; Paclitaxel; Pleural Effusion, Malignant; Pyrazines; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Successful combination therapy with trastuzumab and Paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Docetaxel; Doxorubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Paclitaxel; Pleural Effusion, Malignant; Taxoids; Trastuzumab; Treatment Outcome | 2004 |
[A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Nephritis; Paclitaxel; Pleural Effusion, Malignant; Renal Insufficiency | 2004 |
Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.
Topics: Antineoplastic Agents; Ascites; Blotting, Western; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Doxorubicin; Flavonoids; Humans; Neoplasms; Paclitaxel; Piperidines; Pleural Effusion, Malignant; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured | 2005 |
[Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drainage; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Pleural Effusion, Malignant; Pleurisy | 2005 |
Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurisy; Time Factors; Treatment Outcome | 2006 |
Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents.
Topics: Antineoplastic Agents; Ascitic Fluid; Bone Marrow Cells; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Formazans; Humans; Inhibitory Concentration 50; Male; Neoplasm Metastasis; Neoplasms; Neoplastic Stem Cells; Paclitaxel; Pleural Effusion, Malignant; Tetrazolium Salts | 2006 |
[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].
Topics: Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Paclitaxel; Pleural Effusion, Malignant; Pleural Neoplasms; Quality of Life; Remission Induction; Taxoids; Toremifene | 2007 |
Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Collagen Type I; Drug Screening Assays, Antitumor; Female; Gels; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Teratoma | 2007 |
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Medical Records; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate | 2008 |
[A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Remission Induction | 1999 |
[Administration of docetaxel in cases of recurrent breast carcinoma with malignant pleural effusion controlled by intrapleural administration of OK-432].
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Picibanil; Pleura; Pleural Effusion, Malignant; Taxoids | 1999 |
[Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report].
Topics: Antineoplastic Agents, Phytogenic; Axilla; Breast Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydrothorax; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pleural Effusion, Malignant | 2001 |
Basaloid large cell lung carcinoma presenting concurrently with metastatic uveal tumor.
Topics: Carboplatin; Carcinoma, Large Cell; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pleural Effusion, Malignant; Radionuclide Imaging; Smoking; Tomography; Uveal Neoplasms | 2001 |